Presumed ocular tuberculosis in a developed country: a descriptive retrospective analysis of patients from a tertiary health care centre in the United Kingdom

Purpose To describe the clinical presentation of Tuberculosis uveitis (TBU) in a developed country (tertiary health Care Centre in The UK) and its association with the response to anti-TB treatment (ATT). Methods A retrospective study, in which, we collected data on ocular TB from a tertiary referra...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariam M. Boshra, Amira Stylianidies, Hitesh Agrawal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Journal of the Egyptian Ophthalmological Society
Subjects:
Online Access:https://journals.lww.com/10.4103/ejos.ejos_32_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199246888927232
author Mariam M. Boshra
Amira Stylianidies
Hitesh Agrawal
author_facet Mariam M. Boshra
Amira Stylianidies
Hitesh Agrawal
author_sort Mariam M. Boshra
collection DOAJ
description Purpose To describe the clinical presentation of Tuberculosis uveitis (TBU) in a developed country (tertiary health Care Centre in The UK) and its association with the response to anti-TB treatment (ATT). Methods A retrospective study, in which, we collected data on ocular TB from a tertiary referral center in a developed country from a total of 100 eyes of 56 patients. The collected data were analyzed from the perspective of visual acuity at the presentation and the last visit, clinical presentation, treatment started, and the need for immune suppressive therapy. Results Pan uveitis was the most common clinical presentation (40%). All patients received ATT. Comparing mean baseline visual acuity 0.49±0.65 was slightly reduced to 0.45±0.72 (3 months after completing ATT), however, this difference was not statistically significant. The rate of treatment failure was 44%. Twenty-five patients needed additional immunosuppression (steroid alone or combined with immune suppressive therapy) 3 months after completing the ATT because of persistent inflammation. Conclusion TBU is still a diagnosis that needs to be considered and excluded in developed areas. Long-term Immunosuppressive medication may be needed for cases of TBU with significant intraocular inflammation either during or after ATT. Uveitis pattern and presence or absence of disc edema could predict the need for immunosuppression.
format Article
id doaj-art-4341fa79f8b84885ae67ee7bd5a711fe
institution Kabale University
issn 2090-0686
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of the Egyptian Ophthalmological Society
spelling doaj-art-4341fa79f8b84885ae67ee7bd5a711fe2025-02-08T05:26:14ZengWolters Kluwer Medknow PublicationsJournal of the Egyptian Ophthalmological Society2090-06862025-01-011181273010.4103/ejos.ejos_32_24Presumed ocular tuberculosis in a developed country: a descriptive retrospective analysis of patients from a tertiary health care centre in the United KingdomMariam M. BoshraAmira StylianidiesHitesh AgrawalPurpose To describe the clinical presentation of Tuberculosis uveitis (TBU) in a developed country (tertiary health Care Centre in The UK) and its association with the response to anti-TB treatment (ATT). Methods A retrospective study, in which, we collected data on ocular TB from a tertiary referral center in a developed country from a total of 100 eyes of 56 patients. The collected data were analyzed from the perspective of visual acuity at the presentation and the last visit, clinical presentation, treatment started, and the need for immune suppressive therapy. Results Pan uveitis was the most common clinical presentation (40%). All patients received ATT. Comparing mean baseline visual acuity 0.49±0.65 was slightly reduced to 0.45±0.72 (3 months after completing ATT), however, this difference was not statistically significant. The rate of treatment failure was 44%. Twenty-five patients needed additional immunosuppression (steroid alone or combined with immune suppressive therapy) 3 months after completing the ATT because of persistent inflammation. Conclusion TBU is still a diagnosis that needs to be considered and excluded in developed areas. Long-term Immunosuppressive medication may be needed for cases of TBU with significant intraocular inflammation either during or after ATT. Uveitis pattern and presence or absence of disc edema could predict the need for immunosuppression.https://journals.lww.com/10.4103/ejos.ejos_32_24developed countrytuberculosisuveitis
spellingShingle Mariam M. Boshra
Amira Stylianidies
Hitesh Agrawal
Presumed ocular tuberculosis in a developed country: a descriptive retrospective analysis of patients from a tertiary health care centre in the United Kingdom
Journal of the Egyptian Ophthalmological Society
developed country
tuberculosis
uveitis
title Presumed ocular tuberculosis in a developed country: a descriptive retrospective analysis of patients from a tertiary health care centre in the United Kingdom
title_full Presumed ocular tuberculosis in a developed country: a descriptive retrospective analysis of patients from a tertiary health care centre in the United Kingdom
title_fullStr Presumed ocular tuberculosis in a developed country: a descriptive retrospective analysis of patients from a tertiary health care centre in the United Kingdom
title_full_unstemmed Presumed ocular tuberculosis in a developed country: a descriptive retrospective analysis of patients from a tertiary health care centre in the United Kingdom
title_short Presumed ocular tuberculosis in a developed country: a descriptive retrospective analysis of patients from a tertiary health care centre in the United Kingdom
title_sort presumed ocular tuberculosis in a developed country a descriptive retrospective analysis of patients from a tertiary health care centre in the united kingdom
topic developed country
tuberculosis
uveitis
url https://journals.lww.com/10.4103/ejos.ejos_32_24
work_keys_str_mv AT mariammboshra presumedoculartuberculosisinadevelopedcountryadescriptiveretrospectiveanalysisofpatientsfromatertiaryhealthcarecentreintheunitedkingdom
AT amirastylianidies presumedoculartuberculosisinadevelopedcountryadescriptiveretrospectiveanalysisofpatientsfromatertiaryhealthcarecentreintheunitedkingdom
AT hiteshagrawal presumedoculartuberculosisinadevelopedcountryadescriptiveretrospectiveanalysisofpatientsfromatertiaryhealthcarecentreintheunitedkingdom